If you're covered by Medicare and qualify for the Bridge Program, the $50/month FDA-approved option through a participating pharmacy may represent a materially different cost-benefit calculation than Omzo's compounded program at $199-$399 per month
At Via Nova Health, we customize weight loss plans incorporating GLP-1 injections, ensuring that each patients journey is tailored to their unique needs and goals
In a large Phase 3 clinical trial (STEP series), semaglutide demonstrated excellent weight loss and weight maintenance after weight loss
Novos argument is a shot across the bow for all compounded GLP-1 products, and the industry should expect other manufacturers to follow suit with a wave of similar challenges
Yes, mood changes in early GLP-1 treatment are documented and usually temporary.(8) The medication affects neurological pathways that extend beyond appetite, and the early adjustment period can involve some emotional variability
Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jquier E